Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
NCT00559598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502
Last updated 2012-03-08
Summary
RATIONALE: Studying samples of blood in the laboratory from patients with cancer and from healthy participants may help doctors identify and learn more about proteins related to cancer. It may also help doctors tell whether a patient has cancer.
PURPOSE: This clinical trial is looking at proteins in blood samples to see how well they work in finding pancreatic cancer and extrahepatic biliary tract cancer.
Conditions
- Extrahepatic Bile Duct Cancer
- Pancreatic Cancer
Interventions
- GENETIC
-
proteomic profiling
- OTHER
-
medical chart review
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Lee E. Moore · NCI - Occupational and Environmental Epidemiology Branch
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-08-31
- Completion
- 2009-04-30
More Related Trials
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
The Development of a Metabolomic Test to Diagnose and Quantify Pancreatic Exocrine Insufficiency (The DETECTION Study)
NCT05980221 ·Status: UNKNOWN ·Phase: NA
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661 ·Status: COMPLETED
-
Blood Markers of Early Pancreas Cancer
NCT03568630 ·Status: RECRUITING
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
NCT00830557 ·Status: RECRUITING
-
Pancreatic Cancer Serum and DNA Repository
NCT00296114 ·Status: COMPLETED
-
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
NCT00805688 ·Status: COMPLETED
-
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
NCT02277834 ·Status: COMPLETED
-
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
NCT03060720 ·Status: ACTIVE_NOT_RECRUITING
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
Project Survival-Prospective Biomarker Discovery
NCT02781012 ·Status: UNKNOWN
-
Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303
NCT01664169 ·Status: COMPLETED
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
NCT02361320 ·Status: RECRUITING ·Phase: NA
-
Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
NCT01726582 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
NCT00897832 ·Status: COMPLETED
-
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
NCT02683824 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
NCT00735917 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Pancreatic Cancer Screening
NCT05058846 ·Status: RECRUITING
-
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT03250078 ·Status: RECRUITING
-
Biomarkers Study in Pancreatic Cancer
NCT01666184 ·Status: UNKNOWN
-
Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence
NCT01707758 ·Status: WITHDRAWN
-
Collection of Circulating Biomarkers in Pancreatic Cancer
NCT05743049 ·Status: RECRUITING
-
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
NCT02393703 ·Status: RECRUITING
-
Expression of Inflammatory Proteins in Pancreatic Cancer
NCT00551057 ·Status: UNKNOWN